With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting the Epigenome of Diffuse Intrinsic Pontine Glioma||The Johns Hopkins University School of Medicine / Sama Ahsan, MD||Young Investigator Grants||2014||Maryland|
|Hospital Volume and Induction Mortality in Children, Adolescents, and Young Adults with Acute Leukemia||Children's Hospital of Philadelphia / Jennifer Wilkes, MD||Young Investigator Grants||2014||Pennsylvania|
|Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG||Lucile Packard Children's Hospital at Stanford University School of Medicine / Yujie Tang, PhD||Young Investigator Grants||2014||California|
|Targeted Therapy for Core Binding Factor Leukemia||University of Massachusetts Medical School / John Pulikkan, PhD||Young Investigator Grants||2014||Massachusetts|
|Autophagy and mTOR Inhibition in Pediatric Gliomas with BRAF Mutations||University of Colorado Denver / Jean Mulcahy Levy, MD||Young Investigator Grants||2014||Colorado|
|Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells||Dana-Farber Cancer Institute / Zhaodong Li, PhD||Young Investigator Grants||2014||Massachusetts|
|A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell||The Johns Hopkins University School of Medicine / Jeffrey Huo, MD, PhD||Young Investigator Grants||2014||Maryland|
|APOBEC3 in Pediatric Leukemia: a Biomarker for Sensitivity to PARP Inhibition?||Children's Hospital of Philadelphia / Abby Green, MD||Young Investigator Grants||2014||Pennsylvania|
|Optimizing Engager T-cells for CD19+ Malignancies||Baylor College of Medicine / Mireya Paulina Velasquez, MD||Young Investigator Grants||2014||Texas|
|Understanding and Preventing Healthy Tissue Damage in Pediatric Cancer Patients||Dana-Farber Cancer Institute / Kristopher Sarosiek, PhD||Young Investigator Grants||2014||Massachusetts|